NCT01809431

Brief Summary

The purpose of this study is to determine whether a 14 week intervention is successful in improving outcomes for women with gestational diabetes mellitus and their infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2012

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 12, 2013

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2015

Enrollment Period

2.2 years

First QC Date

March 10, 2013

Last Update Submit

June 11, 2024

Conditions

Keywords

gestational diabeteswomeninfantsblood glucoseweightadiposityhealth behaviorsself-efficacy

Outcome Measures

Primary Outcomes (2)

  • fasting blood glucose

    Change in fasting blood glucose in mothers

    Baseline to 10 months postpartum

  • weight (body mass index)

    Change in weight (body mass index)in mothers

    Baseline to 10 months postpartum

Secondary Outcomes (11)

  • oral glucose tolerance test

    Baseline to 10 months postpartum

  • insulin levels

    Baseline to 10 months postpartum

  • homeostasis model assessment

    Baseline to 10 months postpartum

  • hemoglobin A1c

    Baseline to 10 months postpartum

  • complete lipid panel

    Baseline to 10 months postpartum

  • +6 more secondary outcomes

Study Arms (2)

intervention

EXPERIMENTAL

Breastfeeding, progression to type 2 diabetes, nutrition, and exercise education, coping skills training, exercise training, a home-based exercise program and educational and motivational text messaging.

Behavioral: Intervention

Wait-listed control group

NO INTERVENTION

Wait-listed control group receive usual care delivered by their health care provider and after completion of their time in the study they are offered the intervention

Interventions

InterventionBEHAVIORAL

Using a two-group, repeated measures experimental design, this proposed study will test a 14-week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and type 2 diabetes, nutrition and exercise education, coping skills training, and physical activity (Phase I) and 3 months of continued monthly contact (Phase II) to help overweight women diagnosed with gestational diabetes improve metabolic, clinical, weight, adiposity, health behaviors and self-efficacy.

Also known as: breastfeeding education, progression to prediabetes and type 2 diabetes education, nutrition education, exercise education, coping skills training, exercise training, home-based exercise program, educational and motivational text messaging
intervention

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women between 22-36 weeks of pregnancy who are diagnosed with GDM
  • A diagnosis of GDM during the current pregnancy by two or more 100g Oral Glucose Tolerance Test (OGTT) values exceeding established thresholds (fasting 95, 1h 180, 2h 155, 3h 140 mg/dL)
  • Age 18-45 years old
  • A pre-pregnancy body mass index \> 25kg/m2
  • Ability to read and write in English
  • Willingness to consent for themselves and their infant

You may not qualify if:

  • They have a A1c ≥ 6.5 mg/dL (Type 2 diabetes)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UNC-Rex Health Care

Raleigh, North Carolina, 27607, United States

Location

WakeMed

Raleigh, North Carolina, 27610, United States

Location

Related Publications (2)

  • Stuebe AM, Bonuck K, Adatorwovor R, Schwartz TA, Berry DC. A Cluster Randomized Trial of Tailored Breastfeeding Support for Women with Gestational Diabetes. Breastfeed Med. 2016 Dec;11(10):504-513. doi: 10.1089/bfm.2016.0069. Epub 2016 Oct 26.

  • Berry DC, Neal M, Hall EG, Schwartz TA, Verbiest S, Bonuck K, Goodnight W, Brody S, Dorman KF, Menard MK, Stuebe AM. Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study. BMC Pregnancy Childbirth. 2013 Oct 10;13:184. doi: 10.1186/1471-2393-13-184.

MeSH Terms

Conditions

Diabetes, GestationalBody WeightObesityHealth Behavior

Interventions

MethodsNutrition AssessmentExercise

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersBehavior

Intervention Hierarchy (Ancestors)

Investigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Diane Berry, PhD, ANP-BC

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Alison Stuebe, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2013

First Posted

March 12, 2013

Study Start

May 1, 2012

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

June 13, 2024

Record last verified: 2015-06

Locations